CKD-mineral and bone disorder management in kidney transplant recipients

American Journal of Kidney Diseases

Volumn 61, Issue 2, 2013, Pages 310-325

  Alshayeb, Hala M ^a   Josephson, Michelle A ^a   Sprague, Stuart M ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

diagnosis; epidemiology; management; pathogenesis; Posttransplantation bone disease; screening

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; ALKALINE PHOSPHATASE; AZATHIOPRINE; CALCIMIMETIC AGENT; CALCINEURIN INHIBITOR; CALCITONIN; CALCITRIOL; CALCIUM; CINACALCET; COLECALCIFEROL; CYCLOSPORIN; DENOSUMAB; EVEROLIMUS; FIBROBLAST GROWTH FACTOR 23; GLUCOCORTICOID; IBANDRONIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ODANACATIB; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PHOSPHORUS; RAPAMYCIN; RISEDRONIC ACID; STEROID; TACROLIMUS; VITAMIN D; ZOLEDRONIC ACID;

ALCOHOL ABSTINENCE; APOPTOSIS; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE BIOPSY; BONE DENSITY; BONE DISEASE; BONE RADIOGRAPHY; BONE REMODELING; BONE TURNOVER; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYPERCALCEMIA; HYPOPHOSPHATEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; META ANALYSIS (TOPIC); MINERAL METABOLISM; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PARATHYROIDECTOMY; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSTTRANSPLANTATION BONE DISEASE; RENAL OSTEODYSTROPHY; SMOKING CESSATION; SUPPLEMENTATION; VITAMIN D DEFICIENCY;

AGED; BONE DISEASES, METABOLIC; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MINERALS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84872363362     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.07.022     Document Type: Article

References (161)

1. K. Uhlig, J.S. Berns, B. Kestenbaum KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD) Am J Kidney Dis 55 5 2010 773 799
2. S. Moe, T. Drueke, J. Cunningham Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 69 11 2006 1945 1953
3. V.M. Brandenburg, R. Westenfeld, M. Ketteler The fate of bone after renal transplantation J Nephrol 17 2 2004 190 204
4. E. Stein, P. Ebeling, E. Shane Post-transplantation osteoporosis Endocrinol Metab Clin North Am 36 4 2007 937 963
5. H.H. Malluche, H.W. Mawad, M.C. Monier-Faugere Renal osteodystrophy in the first decade of the new millennium - analysis of 630 bone biopsies in black and white patients J Bone Miner Res 26 6 2011 1368 1376
6. S. Govindarajan, N. Khandelwal, V. Sakhuja, V. Jha Bone mineral density in patients with end-stage renal disease and its evolution after kidney transplantation Indian J Nephrol 21 2 2011 85 89
7. V.M. Brandenburg, D. Politt, M. Ketteler Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation Transplantation 77 10 2004 1566 1571
8. K. Kodras, M. Haas Effect of kidney transplantation on bone Eur J Clin Invest 36 7 2006 S63 S75 (suppl 2)
9. A. Moreno, J.V. Torregrosa, F. Pons, J.M. Campistol, M.J. Martinez de Osaba, F. Oppenheimer Bone mineral density after renal transplantation: long-term follow-up Transplant Proc 31 6 1999 2322 2323
10. J.H. Nam, J.I. Moon, S.S. Chung Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation Transplant Proc 32 7 2000 1876
11. E. Goffin, J.P. Devogelaer, A. Lalaoui Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation Transpl Int 15 2-3 2002 73 80
12. W. Grotz, C. Nagel, D. Poeschel Effect of ibandronate on bone loss and renal function after kidney transplantation J Am Soc Nephrol 12 7 2001 1530 1537
13. W.H. Grotz, F.A. Mundinger, B. Gugel, V.M. Exner, G. Kirste, P.J. Schollmeyer Bone mineral density after kidney transplantation A cross-sectional study in 190 graft recipients up to 20 years after transplantation Transplantation 59 7 1995 982 986
14. M.K. Almond, J.T. Kwan, K. Evans, J. Cunningham Loss of regional bone mineral density in the first 12 months following renal transplantation Nephron 66 1 1994 52 57
15. T.R. Mikuls, B.A. Julian, A. Bartolucci, K.G. Saag Bone mineral density changes within six months of renal transplantation Transplantation 75 1 2003 49 54
16. Y.F. Smets, J.W. de Fijter, J. Ringers, H.H. Lemkes, N.A. Hamdy Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation Kidney Int 66 5 2004 2070 2076
17. V.M. Brandenburg, M. Ketteler, N. Heussen Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones Osteoporos Int 16 12 2005 1611 1620
18. V. Pichette, A. Bonnardeaux, L. Prudhomme, M. Gagne, J. Cardinal, D. Ouimet Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study Am J Kidney Dis 28 1 1996 105 114
19. P.R. Ebeling Approach to the patient with transplantation-related bone loss J Clin Endocrinol Metab 94 5 2009 1483 1490
20. C.A. Kulak, V.Z. Borba, J. Kulak Jr, D.J. Campos, E. Shane Post-transplantation osteoporosis Arq Bras Endocrinol Metabol 54 2 2010 143 149
21. E. Elmstedt, T. Svahn Skeletal complications following renal transplantation Acta Orthop Scand 52 3 1981 279 286
22. J.K. Davidson, D. Tsakiris, J.D. Briggs, B.J. Junor Osteonecrosis and fractures following renal transplantation Clin Radiol 36 1 1985 27 35
23. R. Ramsey-Goldman, J.E. Dunn, D.D. Dunlop Increased risk of fracture in patients receiving solid organ transplants J Bone Miner Res 14 3 1999 456 463
24. E.A. O'Shaughnessy, D.C. Dahl, C.L. Smith, B.L. Kasiske Risk factors for fractures in kidney transplantation Transplantation 74 3 2002 362 366
25. S. Durieux, L. Mercadal, P. Orcel Bone mineral density and fracture prevalence in long-term kidney graft recipients Transplantation 74 4 2002 496 500
26. D.J. Arlen, K. Lambert, G. Ioannidis, J.D. Adachi Treatment of established bone loss after renal transplantation with etidronate Transplantation 71 5 2001 669 673
27. W.H. Grotz, F.A. Mundinger, B. Gugel, V. Exner, G. Kirste, P.J. Schollmeyer Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients Transplantation 58 8 1994 912 915
28. C.R. Parker, A.J. Freemont, P.J. Blackwell, M.J. Grainge, D.J. Hosking Cross-sectional analysis of renal transplantation osteoporosis J Bone Miner Res 14 11 1999 1943 1951
29. S. Patel, J.T. Kwan, E. McCloskey Prevalence and causes of low bone density and fractures in kidney transplant patients J Bone Miner Res 16 10 2001 1863 1870
30. A. D'Angelo, L. Calo, S. Giannini Parathyroid hormone and bone metabolism in kidney-transplanted patients Clin Nephrol 53 4 2000 19 22 (suppl)
31. J.H. Nam, J.I. Moon, S.S. Chung Prevalence and risk factors for vertebral fractures in renal transplants Transplant Proc 32 7 2000 1877
32. S.M. Sprague, M.A. Josephson Bone disease after kidney transplantation Semin Nephrol 24 1 2004 82 90
33. L.M. Vautour, L.J. Melton III, B.L. Clarke, S.J. Achenbach, A.L. Oberg, J.T. McCarthy Long-term fracture risk following renal transplantation: a population-based study Osteoporos Int 15 2 2004 160 167
34. T.P. Van Staa, H.G. Leufkens, L. Abenhaim, B. Zhang, C. Cooper Use of oral corticosteroids and risk of fractures J Bone Miner Res 15 6 2000 993 1000
35. A. Unal, I. Kocyigit, M.H. Sipahioglu Loss of bone mineral density in renal transplantation recipients Transplant Proc 42 9 2010 3550 3553
36. L. Ozel, P. Ata, M.S. Ozel Risk factors for osteoporosis after renal transplantation and effect of vitamin D receptor Bsm I polymorphism Transplant Proc 43 3 2011 858 862
37. A.M. Ball, D.L. Gillen, D. Sherrard Risk of hip fracture among dialysis and renal transplant recipients JAMA 288 23 2002 3014 3018
38. U. Nisbeth, E. Lindh, S. Ljunghall, U. Backman, B. Fellstrom Increased fracture rate in diabetes mellitus and females after renal transplantation Transplantation 67 9 1999 1218 1222
39. K.C. Abbott, R.J. Oglesby, I.O. Hypolite Hospitalizations for fractures after renal transplantation in the United States Ann Epidemiol 11 7 2001 450 457
40. L.E. Nikkel, C.S. Hollenbeak, E.J. Fox, T. Uemura, N. Ghahramani Risk of fractures after renal transplantation in the United States Transplantation 87 12 2009 1846 1851
41. N. Kanaan, K. Claes, J.P. Devogelaer Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss Clin J Am Soc Nephrol 5 10 2010 1887 1892
42. S. Dolgos, A. Hartmann, S. Bonsnes Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation Scand J Clin Lab Invest 69 2 2009 161 167
43. J.W. Braga Jr, R.M. Neves, M.M. Pinheiro Prevalence of low trauma fractures in long-term kidney transplant patients with preserved renal function Braz J Med Biol Res 39 1 2006 137 147
44. R. Marcen, C. Caballero, O. Uriol Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients Transplant Proc 39 7 2007 2256 2258
45. G. Opelz, B. Dohler Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients Transplantation 91 1 2011 65 69
46. C.O. Stehman-Breen, D.J. Sherrard, A.M. Alem Risk factors for hip fracture among patients with end-stage renal disease Kidney Int 58 5 2000 2200 2205
47. R. Mainra, G.J. Elder Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation Clin J Am Soc Nephrol 5 1 2010 117 124
48. E. Rojas, R.G. Carlini, P. Clesca The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling Kidney Int 63 5 2003 1915 1923
49. V. Bonomini, C. Feletti, A. Di Felice, A. Buscaroli Bone remodelling after renal transplantation (RT) Adv Exp Med Biol 178 1984 207 216
50. G. Lehmann, U. Ott, G. Stein, T. Steiner, G. Wolf Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients Transplant Proc 39 10 2007 3153 3158
51. K. Borchhardt, I. Sulzbacher, T. Benesch, M. Fodinger, G. Sunder-Plassmann, M. Haas Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation Am J Transplant 7 11 2007 2515 2521
52. M. Coco, D. Glicklich, M.C. Faugere Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate J Am Soc Nephrol 14 10 2003 2669 2676
53. N.M. Maalouf, E. Shane Osteoporosis after solid organ transplantation J Clin Endocrinol Metab 90 4 2005 2456 2465
54. J.D. Adachi, W.G. Bensen, A.B. Hodsman Corticosteroid-induced osteoporosis Semin Arthritis Rheum 22 6 1993 375 384
55. M.C. Monier-Faugere, H. Mawad, Q. Qi, R.M. Friedler, H.H. Malluche High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation J Am Soc Nephrol 11 6 2000 1093 1099
56. R.S. Weinstein, R.L. Jilka, A.M. Parfitt, S.C. Manolagas Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids Potential mechanisms of their deleterious effects on bone J Clin Invest 102 2 1998 274 282
57. A.A. Khaleeli, R.H. Edwards, K. Gohil Corticosteroid myopathy: a clinical and pathological study Clin Endocrinol (Oxf) 18 2 1983 155 166
58. P.J. Stewart, P.H. Stern Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption Calcif Tissue Int 45 4 1989 222 226
59. M. Schlosberg, C. Movsowitz, S. Epstein, F. Ismail, M.D. Fallon, S. Thomas The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat Endocrinology 124 5 1989 2179 2184
60. R.O. Moreira, L.S. Thiago, F.L. Oliveira Cyclosporine A, but not tacrolimus, is associated with impaired proliferation and differentiation of human osteoblast-like cells in vitro Med Sci Monit 15 3 2009 BR65 BR70
61. C. Movsowitz, S. Epstein, M. Fallon, F. Ismail, S. Thomas Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration Endocrinology 123 5 1988 2571 2577
62. M.A. Josephson, L.P. Schumm, M.Y. Chiu, C. Marshall, J.R. Thistlethwaite, S.M. Sprague Calcium and calcitriol prophylaxis attenuates posttransplant bone loss Transplantation 78 8 2004 1233 1236
63. P.J. Stewart, P.H. Stern Interaction of cyclosporine A and calcitonin on bone resorption in vitro Horm Metab Res 21 4 1989 194 197
64. C.A. Nassar, P.O. Nassar, D.C. Andia, M.R. Guimaraes, L.C. Spolidorio Effects of long-term FK 506 therapy on the alveolar bone and cementum of rats Transplant Proc 41 5 2009 1871 1874
65. R. Westenfeld, G. Schlieper, M. Woltje Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis - implications for post-transplantation bone disease Nephrol Dial Transplant 26 12 2011 4115 4123
66. M. Kneissel, N.H. Luong-Nguyen, M. Baptist Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts Bone 35 5 2004 1144 1156
67. F. Velasquez-Forero, A. Mondragon, B. Herrero, J.C. Pena Adynamic bone lesion in renal transplant recipients with normal renal function Nephrol Dial Transplant 1 suppl 3 1996 58 64
68. R.G. Carlini, E. Rojas, A. Arminio, J.R. Weisinger, E. Bellorin-Font What are the bone lesions in patients with more than four years of a functioning renal transplant? Nephrol Dial Transplant 13 21 1998 S103 S104 (suppl 3)
69. A.M. Cueto-Manzano, S. Konel, A.J. Hutchison Bone loss in long-term renal transplantation: histopathology and densitometry analysis Kidney Int 55 5 1999 2021 2029
70. N.C. Boudville, A.B. Hodsman Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients Nephrol Dial Transplant 21 9 2006 2621 2624
71. P. Messa, C. Sindici, G. Cannella Persistent secondary hyperparathyroidism after renal transplantation Kidney Int. 54 5 1998 1704 1713
72. E. Bertoni, A. Rosati, A. Larti Chronic kidney disease is still present after renal transplantation with excellent function Transplant Proc 38 4 2006 1024 1025
73. S. Pande, C.S. Ritter, M. Rothstein FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation Nephron Physiol 104 1 2006 23 32
74. Economidou D, Dovas S, Papagianni A, Pateinakis P, Memmos D. FGF-23 levels before and after renal transplantation [published online ahead of print May 17, 2009]. J Transplant. doi:10.1155/2009/379082.
75. P. Evenepoel, B.K. Meijers, H. de Jonge Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation Clin J Am Soc Nephrol 3 6 2008 1829 1836
76. A. Trombetti, L. Richert, K. Hadaya Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels Eur J Endocrinol 164 5 2011 839 847
77. T. Cundy, J.A. Kanis, G. Heynen, P.J. Morris, D.O. Oliver Calcium metabolism and hyperparathyroidism after renal transplantation Q J Med 52 205 1983 67 78
78. M. Ramezani, B. Einollahi, M.A. Asl Calcium and phosphorus metabolism disturbances after renal transplantation Transplant Proc 39 4 2007 1033 1035
79. A.M. Straffen, D.J. Carmichael, A. Fairney, B. Hulme, M. Snell Calcium metabolism following renal transplantation Ann Clin Biochem 31 pt 2 1994 125 128
80. D. Babarykin, I. Adamsone, D. Amerika, I. Folkmane, R. Rozental Disorders of calcium metabolism at various times after renal transplantation Ann Transplant 4 1 1999 46 53
81. G.M. London, C. Marty, S.J. Marchais, A.P. Guerin, F. Metivier, M.C. de Vernejoul Arterial calcifications and bone histomorphometry in end-stage renal disease J Am Soc Nephrol 15 7 2004 1943 1951
82. J. Braun, M. Oldendorf, W. Moshage, R. Heidler, E. Zeitler, F.C. Luft Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients Am J Kidney Dis 27 3 1996 394 401
83. S.M. Moe, N.X. Chen [Vascular calcification in end stage renal disease] Clin Calcium 12 10 2002 1417 1422
84. C. Marechal, E. Coche, E. Goffin Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients Am J Kidney Dis 59 2 2012 258 269
85. E. Oschatz, T. Benesch, K. Kodras, U. Hoffmann, M. Haas Changes of coronary calcification after kidney transplantation Am J Kidney Dis 48 2 2006 307 313
86. Kidney Disease: Improving Global Outcomes Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients Am J Transplant 9 suppl 3 2009 S1 S155
87. E.A. Cruz, J.R. Lugon, V. Jorgetti, S.A. Draibe, A.B. Carvalho Histologic evolution of bone disease 6 months after successful kidney transplantation Am J Kidney Dis 44 4 2004 747 756
88. P. Bergmann, J.J. Body, S. Boonen Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club Int J Clin Pract 63 1 2009 19 26
89. D.W. Bates, D.M. Black, S.R. Cummings Clinical use of bone densitometry: clinical applications JAMA 288 15 2002 1898 1900
90. J.A. Kanis Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report WHO Study Group Osteoporos Int 4 6 1994 368 381
91. M. Huang, S.M. Sprague Bone disease in kidney transplant patients Semin Nephrol 29 2 2009 166 173
92. S.M. Sprague The role of the bone biopsy in the diagnosis of renal osteodystrophy Semin Dial 13 3 2000 152 155
93. B.L. Kasiske, M.G. Zeier, J.R. Chapman KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary Kidney Int 77 4 2010 299 311
94. H. Isoniemi, J. Appelberg, C.G. Nilsson, P. Makela, J. Risteli, K. Hockerstedt Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis A 2-year follow-up study J Hepatol 34 2 2001 299 305
95. H.U. Stempfle, C. Werner, S. Echtler Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol Transplantation 68 4 1999 523 530
96. S. Pereira, S. Pedroso, L. Martins Bone mineral density after simultaneous kidney-pancreas transplantation: four years follow-up of 57 recipients Transplant Proc 42 2 2010 555 557
97. M. Hazzan, F. Glowacki, A. Lionet, F. Provot, C. Noel [Weaning from corticosteroid therapy after kidney transplantation] Nephrol Ther 5 suppl 6 2009 S355 S358
98. S.W. Ing, L.T. Sinnott, S. Donepudi, E.A. Davies, R.P. Pelletier, N.E. Lane Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients Clin Transplant 25 2 2011 E113 E123
99. Edwards BJ, Desai A, Tsai J, et al. Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoidsparing immunosuppressive regimens [published online ahead of print September 12, 2011]. J Osteoporos. doi:10.4061/2011/591793.
100. L.E. Nikkel, S. Mohan, A. Zhang Reduced fracture risk with early corticosteroid withdrawal after kidney transplant Am J Transplant 12 3 2012 649 659
101. 3 to prevent bone loss in renal-transplant patients receiving low doses of steroids Transplantation 79 1 2005 108 115
102. G. Sahin, N.S. Yasar, B. Sirmagul, C. Bal, A.U. Yalcin The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study Ren Fail 30 10 2008 992 999
103. S.G. Rostand, D.G. Warnock Introduction to Vitamin D Symposium, March 14, 2008 Clin J Am Soc Nephrol 3 5 2008 1534
104. 3 and calcium carbonate on bone loss associated with long-term renal transplantation Am J Kidney Dis 35 2 2000 227 236
105. P.I. Lobo, M.S. Cortez, W. Stevenson, T.L. Pruett Normocalcemic hyperparathyroidism associated with relatively low 1:25 vitamin D levels post-renal transplant can be successfully treated with oral calcitriol Clin Transplant 9 4 1995 277 281
106. R.W. Steiner, M. Ziegler, N.A. Halasz, B.D. Catherwood, S. Manolagas, L.J. Deftos Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients Transplantation 56 4 1993 843 846
107. A. Torres, S. Garcia, A. Gomez Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation Kidney Int 65 2 2004 705 712
108. G.E. Wilkins, S. Granleese, R.G. Hegele, J. Holden, D.W. Anderson, G.P. Bondy Oncogenic osteomalacia: evidence for a humoral phosphaturic factor J Clin Endocrinol Metab 80 5 1995 1628 1634
109. J.B. Copley, R.P. Wuthrich Therapeutic management of post-kidney transplant hyperparathyroidism Clin Transplant. 25 1 2011 24 39
110. A.E. El-Agroudy, A.A. El-Husseini, M. El-Sayed, T. Mohsen, M.A. Ghoneim A prospective randomized study for prevention of postrenal transplantation bone loss Kidney Int 67 5 2005 2039 2045
111. J.R. Jeffery, W.D. Leslie, M.E. Karpinski, P.W. Nickerson, D.N. Rush Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate Transplantation 76 10 2003 1498 1502
112. S.L. Fan, M.K. Almond, E. Ball, K. Evans, J. Cunningham Pamidronate therapy as prevention of bone loss following renal transplantation Kidney Int 57 2 2000 684 690
113. S.L. Fan, S. Kumar, J. Cunningham Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation Kidney Int 63 6 2003 2275 2279
114. E. Nowacka-Cieciura, T. Cieciura, T. Baczkowska Bisphosphonates are effective prophylactic of early bone loss after renal transplantation Transplant Proc 38 1 2006 165 167
115. S.C. Palmer, D.O. McGregor, G.F. Strippoli Interventions for preventing bone disease in kidney transplant recipients Cochrane Database Syst Rev 3 2007 CD005015
116. M. Haas, Z. Leko-Mohr, P. Roschger Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation Kidney Int 63 3 2003 1130 1136
117. S. Abediazar, M.R. Nakhjavani Effect of alendronate on early bone loss of renal transplant recipients Transplant Proc 43 2 2011 565 567
118. J.V. Torregrosa, D. Fuster, S. Pedroso Weekly risedronate in kidney transplant patients with osteopenia Transpl Int 20 8 2007 708 711
119. A.E. Kruse, U. Eisenberger, F.J. Frey, M.G. Mohaupt The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism Nephrol Dial Transplant 20 7 2005 1311 1314
120. A.L. Serra, A.A. Schwarz, F.H. Wick, H.P. Marti, R.P. Wuthrich Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism Nephrol Dial Transplant 20 7 2005 1315 1319
121. T.R. Srinivas, J.D. Schold, K.L. Womer Improvement in hypercalcemia with cinacalcet after kidney transplantation Clin J Am Soc Nephrol 1 2 2006 323 326
122. N. Leonard, J.H. Brown Persistent and symptomatic post-transplant hyperparathyroidism: a dramatic response to cinacalcet Nephrol Dial Transplant 21 6 2006 1736
123. N. Leca, M. Laftavi, A. Gundroo Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet Am J Transplant 6 10 2006 2391 2395
124. I. Szwarc, A. Argiles, V. Garrigue Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism Transplantation 82 5 2006 675 680
125. A.L. Serra, R. Savoca, A.R. Huber Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients Nephrol Dial Transplant 22 2 2007 577 583
126. J.M. El-Amm, M.D. Doshi, A. Singh Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation Transplantation 83 5 2007 546 549
127. C. Bergua, J.V. Torregrosa, D. Fuster, A. Gutierrez-Dalmau, F. Oppenheimer, J.M. Campistol Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism Transplantation 86 3 2008 413 417
128. A.L. Serra, C. Wuhrmann, R.P. Wuthrich Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism Am J Kidney Dis 52 6 2008 1151 1157
129. G. Gomez Marques, A. Obrador Mulet, A. Vilar Gimeno Treatment with cinacalcet of secondary hyperparathyroidism after renal transplantation Transplant Proc 41 6 2009 2139 2143
130. J.B. Copley, M. Germain, L. Stern Evaluation of cinacalcet HCl treatment after kidney transplantation Transplant Proc 42 7 2010 2503 2508
131. M.E. Cho, Z. Duan, C.E. Chamberlain, J.C. Reynolds, M.S. Ring, R.B. Mannon Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism Transplant Proc 42 9 2010 3554 3558
132. D. Karras, I. Stoykov, W.F. Lems Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-year results from the EFOS Study J Rheumatol 39 3 2012 600 609
133. D. Cejka, T. Benesch, C. Krestan Effect of teriparatide on early bone loss after kidney transplantation Am J Transplant 8 9 2008 1864 1870
134. E.L. Nogueira, A.C. Costa, A. Santana Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: a series of five case reports Transplantation 92 3 2011 316 320
135. A. Mahajan, M. Narayanan, G. Jaffers, L. Concepcion Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH Hemodial Int 13 4 2009 547 550
136. S. Papapoulos, R. Chapurlat, C. Libanati Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension J Bone Miner Res 27 3 2012 694 701
137. P. Evenepoel, K. Claes, D.R. Kuypers, F. Debruyne, Y. Vanrenterghem Parathyroidectomy after successful kidney transplantation: a single centre study Nephrol Dial Transplant 22 6 2007 1730 1737
138. J.D. Kerby, L.W. Rue, H. Blair, S. Hudson, M.T. Sellers, A.G. Diethelm Operative treatment of tertiary hyperparathyroidism: a single-center experience Ann Surg 227 6 1998 878 886
139. E. Kandil, S. Florman, H. Alabbas Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation Am J Med Sci 339 5 2010 420 424
140. S. Collaud, T. Staub-Zahner, A. Trombetti Increase in bone mineral density after successful parathyroidectomy for tertiary hyperparathyroidism after renal transplantation World J Surg 32 8 2008 1795 1801
141. E. Conley, B. Muth, M. Samaniego Bisphosphonates and bone fractures in long-term kidney transplant recipients Transplantation 86 2 2008 231 237
142. E.M. Stein, D. Ortiz, Z. Jin, D.J. McMahon, E. Shane Prevention of fractures after solid organ transplantation: a meta-analysis J Clin Endocrinol Metab 96 11 2011 3457 3465
143. A.A. El-Husseini, A.E. El-Agroudy, M. El-Sayed, M.A. Sobh, M.A. Ghoneim A prospective randomized study for the treatment of bone loss with vitamin D during kidney transplantation in children and adolescents Am J Transplant 4 12 2004 2052 2057
144. J.K. O'Herrin, D.A. Hullett, D.M. Heisey, H.W. Sollinger, B.N. Becker A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function Am J Nephrol 22 5-6 2002 515 520
145. K. Sakhaee Post-renal transplantation hypophosphatemia Pediatr Nephrol 25 2 2010 213 220
146. F. Caravaca, M.A. Fernandez, R. Ruiz-Calero Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients Nephrol Dial Transplant 13 10 1998 2605 2611
147. P. Evenepoel, E. Lerut, M. Naesens Localization, etiology and impact of calcium phosphate deposits in renal allografts Am J Transplant 9 11 2009 2470 2478
148. W. Gwinner, S. Suppa, M. Mengel Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications Am J Transplant 5 8 2005 1934 1941
149. L.V. Riella, H.G. Rennke, M. Grafals, A. Chandraker Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy Am J Kidney Dis 57 4 2011 641 645
150. M. Koc, S. Tuglular, H. Arikan, C. Ozener, E. Akoglu Alendronate increases bone mineral density in long-term renal transplant recipients Transplant Proc 34 6 2002 2111 2113
151. P.D. Miller Is there a role for bisphosphonates in chronic kidney disease? Semin Dial 20 3 2007 186 190
152. P.D. Miller The kidney and bisphosphonates Bone 49 1 2011 77 81
153. A.E. Kruse, U. Eisenberger, F.J. Frey, M.G. Mohaupt Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism Nephrol Dial Transplant 22 8 2007 2362 2365
154. L.W. Peng, J.L. Logan, S.H. James, K.M. Scott, Y.H. Lien Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient Am J Med 120 9 2007 e7 e9
155. C. Seikrit, A. Muhlfeld, H.J. Groene, J. Floege Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic Nat Rev Nephrol 7 4 2011 237 241
156. L. Esposito, L. Rostaing, I. Gennero, M. Mehrenberger, D. Durand, N. Kamar Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient Clin Nephrol 68 4 2007 245 248
157. M. Courbebaisse, C. Diet, M.O. Timsit Effects of cinacalcet in renal transplant patients with hyperparathyroidism Am J Nephrol 35 4 2012 341 348
158. S. Drakopoulos, M. Koukoulaki, T. Apostolou Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation Am J Surg 198 2 2009 178 183
159. P. Evenepoel, K. Claes, D. Kuypers, B. Maes, Y. Vanrenterghem Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study Nephrol Dial Transplant 20 8 2005 1714 1720
160. S.A. Jamal, O. Ljunggren, C. Stehman-Breen Effects of denosumab on fracture and bone mineral density by level of kidney function J Bone Miner Res 26 8 2011 1829 1835
161. P. Leung, M. Pickarski, Y. Zhuo, P.J. Masarachia, L.T. Duong The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking Bone 49 4 2011 623 635